Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients

Clinical trial NCT03366272 · COMPLETED

Trial details

NCT number: NCT03366272
Sponsor: Universität des Saarlandes
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2017-12-05
Primary completion: 2025-01-15
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.